Unknown

Dataset Information

0

US Food and Drug Administration-Mandated Postmarketing Studies for High-risk Cardiovascular Devices Approved 2015-2019.

ABSTRACT:

SUBMITTER: Hidano D 

PROVIDER: S-EPMC8922201 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

US Food and Drug Administration-Mandated Postmarketing Studies for High-risk Cardiovascular Devices Approved 2015-2019.

Hidano Danelle D   Dhruva Sanket S SS   Redberg Rita F RF  

JAMA internal medicine 20220501 5

Similar Datasets

Unknown US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018.
| S-EPMC8292154 | biostudies-literature
Unknown Analysis of Postapproval Clinical Trials of Therapeutics Approved by the US Food and Drug Administration Without Clinical Postmarketing Requirements or Commitments.
| S-EPMC6512282 | biostudies-literature
Unknown Association of expedited review programmes with postmarketing safety events of new drugs approved by the US food and drug administration between 2007 and 2017
| S-EPMC9301790 | biostudies-literature
Unknown Risk of Recall Associated With Modifications to High-risk Medical Devices Approved Through US Food and Drug Administration Supplements.
| S-EPMC10099049 | biostudies-literature
Unknown Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016.
| S-EPMC6248200 | biostudies-literature
Unknown Adverse Events Involving Radiation Oncology Medical Devices: Comprehensive Analysis of US Food and Drug Administration Data, 1991 to 2015.
| S-EPMC5193217 | biostudies-literature
Unknown High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021.
| S-EPMC9641589 | biostudies-literature
Unknown Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration-Approved Drugs.
| S-EPMC5612261 | biostudies-literature
Unknown Three US Food and Drug Administration-approved therapies for chronic GVHD.
| S-EPMC8931512 | biostudies-literature
Unknown Postmarketing all-case surveillance trends and contribution to safety measures of drugs approved in Japan: a cross-sectional survey in 1999-2019.
| S-EPMC9938803 | biostudies-literature